31.49
+0.64%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Pediatrix Medical Group
From its filings with the US Securities and Exchange Commission
Pediatrix Medical Group is based in Sunrise, Florida and is incorporated in Florida. Its shares trade on NYSE under the ticker MD. The SEC classifies its business as hospitals. In the fiscal year to 31 December 2025, it reported revenue of $1.91bn and net income of $165.4m. At that date it held total assets of $2.25bn and shareholders' equity of $865.9m.
Pediatrix is a leading provider of physician services including newborn, maternal-fetal, and other pediatric subspecialty care. Our national network is comprised of affiliated physicians who provide clinical care in 37 states. During 2024, we formalized our practice portfolio management plans, resulting in a decision to exit almost all of our affiliated office-based practices, other than maternal-fetal medicine. As of December 31, 2024, these plans were completed. Additionally, we exited our primary and urgent care service line during 2024 based on a review of the cost and time that would be required to build the platform to scale. At December 31, 2025, our national network comprised approximately 2,295 affiliated physicians, including 1,350 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (“NICUs”), to babies born prematurely or with medical complications. We have over 475 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where our affiliated neonatal physicians practice. Our network also includes other pediatric subspecialists, including over 230 physicians providing pediatric intensive care, 220 physicians providing hospital-based pediatric care, and 20 physicians providing pediatric surgical care.
Quoted from its 10-K, filed 19 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 26 Aug 2008
- Employees
- 400
- Website
- mednax.com ↗
- Head office
- 1301 CONCORD TERRACE, SUNRISE, FL, 33323
- Incorporated in
- FL
- Classification
- Services-Hospitals
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Mark OrdanExecutive Chairman of the Board, Chief Executive Officer, since 2020$1.1m
- Ms. Kasandra RossiChief Financial Officer, Executive Vice President, Treasurer$1.3m
- Ms. Mary Ann MooreExecutive Vice President, Chief Administrative Officer, General Counsel, Company Secretary$2.4m
- Mr. Guy SansoneLead Independent Director$280,001
- Dr. James SwiftDirector, since 2022$3.3m
- Ms. Laura LinynskyIndependent Director$230,001
- Mr. Thomas MceachinIndependent Director$252,501
- Dr. Kurt NewmanIndependent Director
- Mr. Michael RuckerIndependent Director$242,501
- Mr. John StarcherIndependent Director$230,001
- Ms. Shirley WeisIndependent Director$245,001
- Mrs. Sylvia YoungIndependent Director$230,001
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 70
- Environment
- 50
- Social
- 79
- Governance
- 80
- Women in the workforce
- 80%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- MEDNAX Inc possesses several strengths that contribute to its success:
Weaknesses
- Despite its strengths, MEDNAX Inc also faces certain weaknesses:
Opportunities
- MEDNAX Inc can leverage the following opportunities to expand and grow:
Threats
- MEDNAX Inc faces the following threats that may impact its business:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.